Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Nature Immunology
|
November 20, 2012
Re(de)fining the dendritic cell lineage
Ansuman T Satpathy, Xiaodi Wu, Jörn C Albring, et al.
Blood Advances
|
January 10, 2024
Comparison of antibody-based immunotherapeutics for malignant hematological disease in an experimental murine model
Karin Frebel, Jörn C Albring, Anika Wohlgemuth, et al.
Nature Immunology
|
April 29, 2008
Transcription factor Mef2c is required for B cell proliferation and survival after antigen receptor stimulation
Peter R Wilker, Masako Kohyama, Michelle M Sandau, et al.
Bone Marrow Transplantation
|
January 25, 2018
Alloantigen expression on malignant cells and healthy host tissue influences graft-versus-tumor reactions after allogeneic hematopoietic stem cell transplantation
Stella Robert, Jörn C Albring, Karin Frebel, et al.
Blood
|
June 6, 2012
Dual actions of Meis1 inhibit erythroid progenitor development and sustain general hematopoietic cell proliferation
Mi Cai, Ellen M Langer, Jennifer G Gill, et al.
The Journal of Experimental Medicine
|
May 23, 2012
Zbtb46 expression distinguishes classical dendritic cells and their committed progenitors from other immune lineages
Ansuman T Satpathy, Wumesh KC, Jörn C Albring, et al.
The Journal of Experimental Medicine
|
November 5, 2016
Mafb lineage tracing to distinguish macrophages from other immune lineages reveals dual identity of Langerhans cells
Xiaodi Wu, Carlos G Briseño, Vivek Durai, et al.
Bone Marrow Transplantation
|
August 22, 2025
Immune reconstitution in AML and MDS patients undergoing allogeneic hematopoietic cell transplantation (allo-HCT) with treosulfan- or TBI-based conditioning
Lina Kolloch, Philipp Berning, Jörn C Albring, et al.
The Journal of Experimental Medicine
|
November 17, 2010
Targeting of B and T lymphocyte associated (BTLA) prevents graft-versus-host disease without global immunosuppression
Jörn C Albring, Michelle M Sandau, Aaron S Rapaport, et al.
Bone Marrow Transplantation
|
February 1, 2020
Monitoring minimal residual/relapsing disease after allogeneic haematopoietic stem cell transplantation in adult patients with acute lymphoblastic leukaemia
Klaus Wethmar, Svenja Matern, Eva Eßeling, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Nature Immunology
|
November 20, 2012
Re(de)fining the dendritic cell lineage
Ansuman T Satpathy, Xiaodi Wu, Jörn C Albring, et al.
Blood Advances
|
January 10, 2024
Comparison of antibody-based immunotherapeutics for malignant hematological disease in an experimental murine model
Karin Frebel, Jörn C Albring, Anika Wohlgemuth, et al.
Nature Immunology
|
April 29, 2008
Transcription factor Mef2c is required for B cell proliferation and survival after antigen receptor stimulation
Peter R Wilker, Masako Kohyama, Michelle M Sandau, et al.
Bone Marrow Transplantation
|
January 25, 2018
Alloantigen expression on malignant cells and healthy host tissue influences graft-versus-tumor reactions after allogeneic hematopoietic stem cell transplantation
Stella Robert, Jörn C Albring, Karin Frebel, et al.
Blood
|
June 6, 2012
Dual actions of Meis1 inhibit erythroid progenitor development and sustain general hematopoietic cell proliferation
Mi Cai, Ellen M Langer, Jennifer G Gill, et al.
The Journal of Experimental Medicine
|
May 23, 2012
Zbtb46 expression distinguishes classical dendritic cells and their committed progenitors from other immune lineages
Ansuman T Satpathy, Wumesh KC, Jörn C Albring, et al.
The Journal of Experimental Medicine
|
November 5, 2016
Mafb lineage tracing to distinguish macrophages from other immune lineages reveals dual identity of Langerhans cells
Xiaodi Wu, Carlos G Briseño, Vivek Durai, et al.
Bone Marrow Transplantation
|
August 22, 2025
Immune reconstitution in AML and MDS patients undergoing allogeneic hematopoietic cell transplantation (allo-HCT) with treosulfan- or TBI-based conditioning
Lina Kolloch, Philipp Berning, Jörn C Albring, et al.
The Journal of Experimental Medicine
|
November 17, 2010
Targeting of B and T lymphocyte associated (BTLA) prevents graft-versus-host disease without global immunosuppression
Jörn C Albring, Michelle M Sandau, Aaron S Rapaport, et al.
Bone Marrow Transplantation
|
February 1, 2020
Monitoring minimal residual/relapsing disease after allogeneic haematopoietic stem cell transplantation in adult patients with acute lymphoblastic leukaemia
Klaus Wethmar, Svenja Matern, Eva Eßeling, et al.
Page
of 2